Back to Search Start Over

Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats

Authors :
Costa, Maria A.
Verrilli, Maria A. Lopez
Gomez, Karina A.
Nakagawa, Pablo
Pena, Clara
Arranz, Cristina
Gironacci, Mariela M.
Source :
The American Journal of Physiology. Oct, 2010, Vol. 299 Issue 4, pH1205, 7 p.
Publication Year :
2010

Abstract

It has been shown that angiotensin (ANG)-(1-7) activates nitric oxide synthase (NOS) in isolated ventricular myocytes from normotensive rats. Since many ANG-(1-7) actions are enhanced in situations of increased ANG II activity, as in hypertension, in this study we investigated the in vivo effect of ANG-(1-7) on NOS activity and expression of endothelial (eNOS), neuronal (nNOS), and inducible NOS (iNOS) in ventricles from spontaneously hypertensive rats (SHR). Rats were subjected to a 60-min ANG-(1-7) infusion (0.35 nmol/min); controls received saline. NOS activity was measured using the NADPH diaphorase histochemical method and by the conversion of L-[[sup.14]C]arginine to citrulline, and NOS phosphorylation and expression were determined using Western blotting. In SHR, ANG-(1-7) infusion diminished mean arterial pressure from 180 [+ or -] 9 to 146 [+ or -] 9 mmHg (P < 0.05), and this effect was prevented by nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor. In addition, NOS activity and eNOS phosphorylation were increased by ANG-(1-7) infusion. Ventricular eNOS and nNOS expression were increased 67.4 [+ or -] 6.4 and 51 [+ or -] 10%, respectively, by ANG-(1-7), whereas iNOS was not changed. In another set of experiments, we evaluated the mechanism by which ANG-(1-7) modifies NOS activity. Isolated ventricle slices preincubated with ANG-(1-7) showed an increase in NOS activity and eNOS phosphorylation, which was blocked by an [AT.sub.2] and a bradykinin [B.sub.2] receptor antagonist, but not by the Mas receptor antagonist. Our results show that in rats in a hypertensive state, ANG-(1-7) infusion upregulates cardiac NOS expression and activity through an [AT.sub.2]- and bradykinin-dependent mechanism. In this way ANG-(1-7) may eficit its cardioprotective action and contribute to some of the counterregulatory [AT.sub.2] receptor effects that oppose the [AT.sub.1] receptor-mediated effects. receptors; hypertension; heart; bradykinin doi: 10.1152/ajpheart.00850.2009.

Details

Language :
English
ISSN :
00029513
Volume :
299
Issue :
4
Database :
Gale General OneFile
Journal :
The American Journal of Physiology
Publication Type :
Academic Journal
Accession number :
edsgcl.240912688